Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorothee Speiser

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2014
Radical vaginal trachelectomy after laparoscopic staging and neoadjuvant chemotherapy in women with early-stage cervical cancer over 2 cm: oncologic, fertility, and neonatal outcome in a series of 20 patientsMalgorzata Lanowska, Mandy Mangler, Dorothee Speiser, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2026
Not all information is equally important: informed consent to genetic testing for hereditary cancerPaula Thomas, Sven Asmussen, Katharina Klein, et al.
Genetics in Medicine Open|December 23, 2024
iKNOW-Supporting the counseling of women with hereditary risk of breast and ovarian cancer with digital technologies: A randomized controlled trialMarkus A Feufel, Dorothee Speiser, Stephen Schüürhuis, et al.
JMIR Formative Research|April 21, 2023
Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW)Dorothee Speiser, Maren Heibges, Laura Besch, et al.
Nature Communications|December 19, 2025
Recombination junctions from antibody isotype switching classify immune and DNA repair dysfunctionClara Vázquez García, Benedikt Obermayer, Baerbel Keller, et al.
International Journal of Cancer|April 5, 2014
Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancerKarin Kast, Rita K Schmutzler, Kerstin Rhiem, et al.
Breast Care (Basel, Switzerland)|June 1, 2023
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast CancerKerstin Rhiem, Silke Zachariae, Anke Waha, et al.
Cancer|June 20, 2020
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance surveyNathalie Rippinger, Christine Fischer, Markus W Haun, et al.
Breast Cancer Research and Treatment|February 7, 2019
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancerUlrich Bick, Christoph Engel, Barbara Krug, et al.
Nature Genetics|February 5, 2025
Quantifying cell divisions along evolutionary lineages in cancerMartin Blohmer, David M Cheek, Wei-Ting Hung, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2014
Radical vaginal trachelectomy after laparoscopic staging and neoadjuvant chemotherapy in women with early-stage cervical cancer over 2 cm: oncologic, fertility, and neonatal outcome in a series of 20 patientsMalgorzata Lanowska, Mandy Mangler, Dorothee Speiser, et al.
Journal of Cancer Research and Clinical Oncology|January 27, 2026
Not all information is equally important: informed consent to genetic testing for hereditary cancerPaula Thomas, Sven Asmussen, Katharina Klein, et al.
Genetics in Medicine Open|December 23, 2024
iKNOW-Supporting the counseling of women with hereditary risk of breast and ovarian cancer with digital technologies: A randomized controlled trialMarkus A Feufel, Dorothee Speiser, Stephen Schüürhuis, et al.
JMIR Formative Research|April 21, 2023
Paradigmatic Approach to Support Personalized Counseling With Digital Health (iKNOW)Dorothee Speiser, Maren Heibges, Laura Besch, et al.
Nature Communications|December 19, 2025
Recombination junctions from antibody isotype switching classify immune and DNA repair dysfunctionClara Vázquez García, Benedikt Obermayer, Baerbel Keller, et al.
International Journal of Cancer|April 5, 2014
Validation of the Manchester scoring system for predicting BRCA1/2 mutations in 9,390 families suspected of having hereditary breast and ovarian cancerKarin Kast, Rita K Schmutzler, Kerstin Rhiem, et al.
Breast Care (Basel, Switzerland)|June 1, 2023
Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast CancerKerstin Rhiem, Silke Zachariae, Anke Waha, et al.
Cancer|June 20, 2020
Cancer surveillance and distress among adult pathogenic TP53 germline variant carriers in Germany: A multicenter feasibility and acceptance surveyNathalie Rippinger, Christine Fischer, Markus W Haun, et al.
Breast Cancer Research and Treatment|February 7, 2019
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancerUlrich Bick, Christoph Engel, Barbara Krug, et al.
Nature Genetics|February 5, 2025
Quantifying cell divisions along evolutionary lineages in cancerMartin Blohmer, David M Cheek, Wei-Ting Hung, et al.
Pageof 5